0.1450
0.0000
(0.00%)
At close: August 1 at 9:30:00 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,193.5970
-1,996.5220
-4,642.1000
-2,324.6110
Investing Cash Flow
-7.9500
190.3270
1,292.4840
-314.8890
Financing Cash Flow
2,137.2140
2,609.5410
3,584.5970
4,433.0180
Cash Flow from Discontinued Operation
--
--
--
-1,382.0020
End Cash Position
1,081.4760
1,566.6910
763.3450
528.3640
Capital Expenditure
--
-12.5010
-8.6810
--
Issuance of Capital Stock
2,137.2140
2,259.5410
3,584.5970
3,968.0530
Issuance of Debt
--
--
--
450.0000
Free Cash Flow
-1,201.5470
-2,009.0230
-4,650.7810
-2,324.6110
12/31/2020 - 8/22/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIANY LianBio
0.2630
0.00%
LOBEF Lobe Sciences Ltd.
0.0019
0.00%
ONCO.CN Onco-Innova
1.2000
0.00%
LOBE.CN Lobe Sciences Ltd.
0.0250
0.00%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%
EDSA Edesa Biotech, Inc.
1.7750
-1.39%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
IPA ImmunoPrecise Antibodies Ltd.
0.5285
-2.85%
CYBN.NE Cybin Inc.
12.85
-7.22%
OCEA Ocean Biomedical, Inc.
0.6318
-5.43%